Comprehensive Hemophilia Care Region VI - Arkansas, Louisiana, Oklahoma, Texas

Home Patient Care Educational      Brochures Consumer      Organizations Links Contact

The Louisiana Center for Bleeding and Clotting Disorders Tulane University Health Sciences Center 1430 Tulane Avenue New Orleans, LA 70112-2699 504-988-5433 http://www1.omi.tulane.edu The Louisiana Comprehensive Hemophilia Care Center diagnoses, evaluates and treats patients with congenital and acquired conditions of bleeding such as hemophilia, von Willebrand disease and other rare factor deficiencies.  Located at the Tulane University School of Medicine in New Orleans, La. with an outreach clinic in Lafayette, La. our specialized, multi-disciplinary clinic is open to all ages.  Patients from Louisiana and the gulf coast region may be referred by their physician or may self-refer. The Center is the only federally-funded hemophilia treatment center (HTC) in Louisiana and offers a comprehensive model of care which includes evaluation and treatment recommendations from hematology, nursing, physical therapy, social work, dental and orthopedic services.  This approach has been proven to address health and emotional issues of patients with this chronic disease.  The HTC also offers a home infusion program that allows for prompt therapy to reduce bleeding complications, as well as access to new therapies through numerous clinical research trials.  In addition, the HTC operates a 340B program by which patients can obtain their clotting factor concentrates at reduced costs to help maintain insurance coverage. Thrombosis clinic The formation of clots is called a thrombosis. A clot can occur anywhere in the vascular system and can potentially be life threatening depending on the location. Clotting can also lead to problems during pregnancy including poor fetal growth, separation of the placenta from the uterine wall and miscarriage. It is believed that up to half of women who develop a thrombosis during pregnancy could have an underlying congenital or acquired thrombophilia. Treatments for clotting involve the use of blood thinning drugs such as warfarin and low molecular weight heparins. Our thrombosis clinic serves patients who are genetically predisposed to clotting, as well as those patients with acquired thrombophilia.  We offer genetic testing, counseling, the most recent advances in anticoagulation management, patient education, and patient advocacy to those who are affected by thrombosis. Thrombosis patients are seen by Dr. Cindy Leissinger and Dr. Rebecca Kruse-Jarres. Both are hematologists that specialized in hemostasis, thrombosis and platelet dysfunctions. Referrals can be made by contacting Alicia Cole RN, BSN at 504 988-5433 or acole@tulane.edu.